Global Support For Easing Vaccine Patent Rules Grows

The video discusses the debate over temporarily easing patent protections on COVID-19 vaccines. Countries like France support the waiver, while the US has also shown support. However, Big Pharma argues that waiving IP rights won't solve production issues and could lead to mismanagement. The waiver faces challenges as all 164 WTO members must approve it, with mixed reactions from countries like Australia and South Korea.

Which countries have shown support for the temporary easing of patent protections on COVID-19 vaccines?

• France, Germany, China, and the EU

• Brazil, Russia, India, and South Africa

• United States, Canada, Mexico, and Japan

• Australia, New Zealand, South Korea, and Japan

Which two countries initially proposed the waiver of intellectual property protections on COVID-19 vaccines?

• China and Russia

• South Africa and India

• Brazil and Argentina

• United States and Canada

What is one of the main concerns of pharmaceutical companies regarding the waiver of intellectual property rights?

• Loss of market share

• Mismanagement of scarce resources

• Lack of demand for vaccines

• Increased production costs

What is required for the World Trade Organization to approve the patent waiver?

• Unanimous approval from all 164 members

• Approval from the United Nations

• Majority vote from member countries

• Endorsement from the World Health Organization

What is the stance of the Australian Prime Minister on the US position regarding the patent waiver?

• Great news but no support indicated

• Complete opposition

• Full support

• Neutral stance